PMC:7204663 / 557-754 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":19,"end":28},"obj":"Body_part"},{"id":"T3","span":{"begin":165,"end":174},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma63836"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma63836"}],"text":" the intracellular lysosomal space, which has been implicated as a target site for antiviral activity. The properties of both drugs predict dramatic accumulation in lysosomes, with calculated lysos"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T5","span":{"begin":19,"end":28},"obj":"http://purl.obolibrary.org/obo/GO_0005764"},{"id":"T6","span":{"begin":42,"end":45},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T7","span":{"begin":65,"end":66},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T8","span":{"begin":93,"end":101},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T9","span":{"begin":165,"end":174},"obj":"http://purl.obolibrary.org/obo/GO_0005764"}],"text":" the intracellular lysosomal space, which has been implicated as a target site for antiviral activity. The properties of both drugs predict dramatic accumulation in lysosomes, with calculated lysos"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T10","span":{"begin":83,"end":92},"obj":"Chemical"},{"id":"T11","span":{"begin":126,"end":131},"obj":"Chemical"}],"attributes":[{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A11","pred":"chebi_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":" the intracellular lysosomal space, which has been implicated as a target site for antiviral activity. The properties of both drugs predict dramatic accumulation in lysosomes, with calculated lysos"}